文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期，新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

2020 年食管癌流行病学及 2030 年和 2040 年预测。

Epidemiology of esophageal cancer in 2020 and projections to 2030 and 2040.

机构信息

Department of Thoracic Surgery, Beijing Friendship Hospital, Capital Medical University, Beijing, China.

School of Pharmaceutical Sciences, Wuhan University, Wuhan, China.

出版信息

Thorac Cancer. 2023 Jan;14(1):3-11. doi: 10.1111/1759-7714.14745. Epub 2022 Dec 8.

DOI:10.1111/1759-7714.14745
PMID:36482832
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9807450/
Abstract

Esophageal cancer is a familiar malignancy with high incidence and mortality, and the overall prognosis is poor. The numbers of cases of and deaths from esophageal cancer have risen rapidly in recent decades. It is one of the most malignant cancers, with more than 0.6 million new cases and 0.54 million deaths worldwide in 2020. Here, we present the global epidemiology of esophageal cancer in 2020 and projections to 2030 and 2040 at different geographical levels of continents, regions and countries, and analyze them by gender, race, geographic region and human development index. We summarize the prospects for the esophageal cancer burden and risk factors in different areas, which will be useful for global esophageal cancer clinical therapy and cancer control planning.

摘要

食管癌是一种发病率和死亡率都很高的常见恶性肿瘤，整体预后较差。近几十年来，食管癌的发病人数和死亡人数迅速上升。它是最恶性的癌症之一，2020 年全球有超过 60 万例新发病例和 54 万例死亡病例。在这里，我们展示了 2020 年全球食管癌的流行病学数据，并对 2030 年和 2040 年不同地理层面的大洲、地区和国家进行了预测，并按性别、种族、地理区域和人类发展指数进行了分析。我们总结了不同地区食管癌负担和危险因素的前景，这将有助于全球食管癌的临床治疗和癌症控制规划。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/320e/9807450/993264f8c9e4/TCA-14-3-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/320e/9807450/a6f7b8c33130/TCA-14-3-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/320e/9807450/ac1caae9c24f/TCA-14-3-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/320e/9807450/e141e40155e2/TCA-14-3-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/320e/9807450/f03332757159/TCA-14-3-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/320e/9807450/993264f8c9e4/TCA-14-3-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/320e/9807450/a6f7b8c33130/TCA-14-3-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/320e/9807450/ac1caae9c24f/TCA-14-3-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/320e/9807450/e141e40155e2/TCA-14-3-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/320e/9807450/f03332757159/TCA-14-3-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/320e/9807450/993264f8c9e4/TCA-14-3-g005.jpg

相似文献

[1]
Epidemiology of esophageal cancer in 2020 and projections to 2030 and 2040.

Thorac Cancer. 2023-1

[2]
Global trends in the incidence and mortality of esophageal cancer from 1990 to 2017.

Cancer Med. 2020-9

[3]
Global trends in esophageal cancer.

J Surg Oncol. 2017-4

[4]
Epidemiological landscape of esophageal cancer in Asia: Results from GLOBOCAN 2020.

Thorac Cancer. 2023-4

[5]
The global, regional, and national burden of oesophageal cancer and its attributable risk factors in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.

Lancet Gastroenterol Hepatol. 2020-4-1

[6]
Changing trends in the disease burden of esophageal cancer in China from 1990 to 2017 and its predicted level in 25 years.

Cancer Med. 2021-3

[7]
Burden of esophageal cancer and its attributable risk factors in 204 countries and territories from 1990 to 2019.

Front Public Health. 2022

[8]
Epidemiology of esophageal cancer: update in global trends, etiology and risk factors.

Clin J Gastroenterol. 2020-12

[9]
A Multinational Assessment of Gastric, Esophageal, and Colorectal Cancer Burden: A Report of Disease Incidence, Prevalence, and Fatality.

J Gastrointest Cancer. 2020-9

[10]
Shared susceptibility loci at 2q33 region for lung and esophageal cancers in high-incidence areas of esophageal cancer in northern China.

PLoS One. 2017-5-18

引用本文的文献

[1]
Different types of oesophageal reconstructions in the contemporary era: a systematic review and network meta-analysis.

Ir J Med Sci. 2025-8-29

[2]
Investigating Nutrition and Supportive Care Needs in Esophageal and Gastric Cancer Survivors: A Cross-Sectional Survey.

Healthcare (Basel). 2025-8-20

[3]
Global Hypomethylation as Minimal Residual Disease (MRD) Biomarker in Esophageal and Esophagogastric Junction Adenocarcinoma.

Cancers (Basel). 2025-8-15

[4]
Radiation dose escalation in locally advanced oesophageal cancer: a systematic review and hierarchical Bayesian meta-analysis.

EClinicalMedicine. 2025-8-13

[5]
Risk modeling for esophageal cancer based on adaptive Lasso and Cox regression.

Front Oncol. 2025-8-1

[6]
Regulation of RHBDD1 in the invasion of esophageal cancer cells via ELK3/Wnt/β-catenin signaling pathway.

Front Bioeng Biotechnol. 2025-7-25

[7]
Quantitative image analysis of the extracellular matrix of esophageal squamous cell carcinoma and high grade dysplasia via two-photon microscopy.

Sci Rep. 2025-8-7

[8]
Prevalence of recurrent nerve injury among esophageal cancer patients undergoing esophagectomy: A systematic review and meta-analysis.

Surg Open Sci. 2025-5-30

[9]
Characteristics of early- versus late-onset esophageal adenocarcinoma: insights from the National Inpatient Sample 2016-2020.

Ann Gastroenterol. 2025

[10]
Robotic-assisted versus conventional minimally invasive esophagectomy: a retrospective cohort study from a high-volume center.

J Robot Surg. 2025-7-22

本文引用的文献

[1]
Esophageal cancer: emerging therapeutics.

Expert Opin Ther Targets. 2022-2

[2]
Potential roles of gastroesophageal reflux in patients with superficial esophageal squamous cell carcinoma without major causative risk factors.

J Gastroenterol. 2021-10

[3]
Long-term effectiveness of one-time endoscopic screening for esophageal cancer: A community-based study in rural China.

Cancer. 2020-10-15

[4]
Burden, trends, and risk factors of esophageal cancer in China from 1990 to 2017: an up-to-date overview and comparison with those in Japan and South Korea.

J Hematol Oncol. 2020-11-2

[5]
Epidemiology of esophageal cancer: update in global trends, etiology and risk factors.

Clin J Gastroenterol. 2020-12

[6]
Long-term outcomes and safety of radical transmediastinal esophagectomy with preoperative docetaxel, cisplatin, and 5-fluorouracil combination chemotherapy for locally advanced squamous cell carcinoma of the thoracic esophagus.

World J Surg Oncol. 2020-9-22

[7]
Prediagnostic circulating levels of sex hormones and survival in esophageal adenocarcinoma.

Int J Cancer. 2021-2-15

[8]
Should adenosquamous esophageal cancer be treated like adenocarcinoma or squamous cell carcinoma?

J Surg Oncol. 2020-5-27

[9]
The global, regional, and national burden of oesophageal cancer and its attributable risk factors in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.

Lancet Gastroenterol Hepatol. 2020-4-1

[10]
Systematic Review with Meta-analysis: Association of Helicobacter pylori Infection with Esophageal Cancer.

Gastroenterol Res Pract. 2019-12-1

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索